Rare Diseases: Psychological Aspects Related to Preimplantation Genetic Testing in the Detection of Monogenic Diseases

Authors

  • Susana Portela Pérez IVI Clinic, Vigo, Spain and ADICAM Clinical Oncology Research Group, Cangas, Spain
  • Agustina Ramos Gutiérrez IVI Clinic, Vigo, Spain
  • Lucía Cameselle-Cortizo ADICAM Clinical Oncology Research Group, Cangas, Spain and Geriatrics Department, Meixoeiro Hospital, Vigo, Spain
  • María Ojeda Varela Clinical Embryologist, IVI Clinic, Vigo, Spain
  • Vanesa Rodríguez-Fernández Department of Obstetrics and Gynecology, Álvaro Cunqueiro University Hospital Complex, Vigo, Spain
  • Jorge F. Cameselle-Teijeiro ADICAM Clinical Oncology Research Group, Cangas, Spain and Primary Care, Vigo, Spain

DOI:

https://doi.org/10.14738/bjhr.1204.19056

Keywords:

Preimplantation Genetic Testing, Rare Genetic Disorders, Psychological Support, Genetic Counseling

Abstract

Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) offers families affected by rare genetic conditions a powerful tool to prevent the transmission of severe inherited diseases. However, the psychological journey associated with this process is often complex and emotionally intense. This article explores the emotional experiences, ethical dilemmas, and decision-making challenges faced by couples who pursue PGT-M, particularly when there is a known family history of rare disorders. Drawing from clinical experience and current literature, we highlight the importance of clear communication, comprehensive genetic counseling, and continuous psychological support throughout the fertility journey. Addressing issues such as anxiety, guilt, partner dynamics, and expectations management can significantly improve outcomes and emotional well-being. As advances in genetic testing become more accessible, healthcare professionals must be prepared to accompany patients not only through the medical process but also through the emotional and ethical landscape that PGT-M entails.

References

Korf BR, Pyeritz RE, and Grody WW, “Nature and Frequency of Genetic Disease,” in Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics, Seventh ed., eds. Pyeritz RE, Korf BR, and Grody WW (Amsterdam, The Netherlands: Academic Press, 2019), 47–51. 92

Blencowe H, Moorthie S, Petrou M, Hamamy H, Povey S, Bittles A, Gibbons S, Darlison M, Modell B; Congenital Disorders Expert Group. Rare single gene disorders: estimating baseline prevalence and outcomes worldwide. J Community Genet. 2018 Oct; 9(4):397-406.

Basille C, Frydman R, El Aly A, Hesters L, Fanchin R, Tachdjian G, et al. Preimplantation genetic diagnosis: State of the art. European Journal of Obstetrics &Gynecology and Reproductive Biology. 2009; 145(1):9-13.

Hershberger PE, Schoenfeld C, Tur-Kaspa I. Unraveling preimplantation genetic diagnosis for high-risk couples: implications for nurses at the front line of care. Nursing for Women’s Health. 2011b; 15(1):36-45.

Simpson JL. Preimplantation genetic diagnosis at 20 years. Prenatal Diagnosis. 2010; 30(7):682-695.

Cahill D J, Wardle P G. Management of infertility BMJ 2002; 325:328.

Domar, A. D., Clapp, D., Slawsby, E., Kessel, B., Orav, J., & Freizinger, M. (2000). The impact of group psychological interventions on distress in infertile women. Health Psychology 2000; 19(6): 568–575.

Dolz, P. y García, A. Incidencia positiva de los Programas de Apoyo Psicológicos en los Tratamientos de Reproducción Asistida. Revista Iberoamericana de Fertilidad y Reproducción Humana. Número especial del 24 Congreso de la Sociedad Española de Fertilidad, 2002; 233.

Mertes H, Harper J, Boivin J, Ekstrand Ragnar M, Grace B, Moura-Ramos M, Rautakallio-Hokkanen S, Simopoulou M, Hammarberg K, International Reproductive Health Education Collaboration Irhec OBOT. Stimulating fertility awareness: the importance of getting the language right. Hum Reprod Open. 2023; (2):hoad009.

Rosenzweig MQ. Breaking bad news: a guide for effective and empathetic communication. Nurse Pract. 2012;

Childress KJ, Lawson AK, Ghant MS, Mendoza G, Cardozo ER, Confino E, Marsh EE. First contact: the intersection of demographics, knowledge, and appraisal of treatment at the initial infertility visit. Fertil Steril. 2015; 104(1):180-187.

Katyala N., Poulsena C.M., Knudsen U.B., Frederiksend Y. The association between psychosocial interventions and fertility treatment outcome: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021;259:125-132.

Cheng L, Meiser B, Kirk E, Kennedy D, Barlow-Stewart K, Kaur R. Factors influencing patients' decisionmaking about preimplantation genetic testing for monogenic disorders. Hum Reprod. 2022; 37(11):2599-2610.

Donarelli Z, Lo Coco G, Gullo S, Marino A, Volpes A, Allegra A. Are attachment dimensions associated with infertility-related stress in couples undergoing their first IVF treatment? A study on the individual and crosspartner effect. Hum Reprod. 2012; 27(11):3215-3225.

Hughes T, Bracewell-Milnes T, Saso S, Jones BP, Almeida PA, Maclaren K, Norman-Taylor J, Johnson M, Nikolaou D. A review on the motivations, decision-making factors, attitudes and experiences of couples using pre-implantation genetic testing for inherited conditions. Hum Reprod Update. 2021; 27(5):944-966.

Tabrizi SJ, Flower MD, Ross CA, Wild EJ. Huntington Disease: New Insights into Molecular Pathogenesis and Therapeutic Opportunities. Nat Rev Neurol2020;16:529–546.

Warby SC, Montpetit A, Hayden AR, et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009; 84:351–366.

Semaka A, Collins JA, Hayden MR. Unstable familial transmissions of Huntington disease alleles with 27-35 CAG repeats (intermediate alleles). Am J Med Genet B Neuropsychiatr Genet 2010; 153B:314–320.

Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Wheeler V, MacDonald ME, Gusella JF and Myers RH. Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27–35 CAG). Am J Med Genet 2009; 149A: 1375-1381.

Hershberger PE, Sipsma H, Finnegan L, Hirshfeld-Cytron J. Razones por las que las mujeres jóvenes aceptan o declinan la preservación de la fertilidad después del diagnóstico de cáncer. J Obstet Gynecol Neonatal Nurs 2016; 45(1):123-134.

Rubin LR, Werner-Lin A, Sagi M, Cholst I, Stern R, Lilienthal D, Hurley K. 'The BRCA clock is ticking!': negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis. Hum Fertil (Camb). 2014, 17(3):159-164.

Quinn GP, Vadaparampil ST, King LM, Miree CA, Friedman S. Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer. Fam Cancer. 2009; 8(4):441-449.

Hurley K, Rubin LR, Werner-Lin A, Sagi M, Kemel Y, Stern R, Phillips A, Cholst I, Kauff N, Offit K. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences. Cancer; 2012:

Rubin LR, Pastore LM, Subramony S, Lobel M, Stelling J. Navigating preimplantation genetic testing decisions in the age of social media: a qualitative study. Fertil Steril 2018; 110:e146.

Ussher JM, Parton C, Perz J. Need for information, honesty and respect: patient perspectives on health care professionals communication about cancer and fertility. Reprod Health. 2018; 15(1):2.

Genoff Garzon MC, Rubin LR, Lobel M, Stelling J, Pastore LM. Review of patient decision-making factors and attitudes regarding preimplantation genetic diagnosis. Clin Genet 2018; 94:22-42.

Katz MG, Fitzgerald L, Bankier A, Savulescu J, Cram DS. Issues and concerns of couples presenting for preimplantation genetic diagnosis (PGD). PrenatDiagn 2002; 22:1117–1122.

van Rij MC, Gielen M, Lulofs R, Evers JL, van Osch L, Muntjewerff N, Geraedts JP, de Die-Smulders CE. Profiles and motives for PGD: a prospective cohort study of couples referred for PGD in the Netherlands. Hum Reprod 2011; 26:1826–1835.

Karatas JC, Barlow-Stewart K, Meiser B, McMahon C, Strong KA, Hill W, Roberts C, Kelly P. Psychological adjustment, knowledge and unmet information needs in women undergoing PGD. Hum Reprod 2010; 25:1481–1489.

Drazba KT, Kelley MA, Hershberger PE. A qualitative inquiry of the financial concerns of couples opting to use preimplantation genetic diagnosis to prevent the transmission of known genetic disorders. J Genet Couns. 2014; 23(2):202-211.

Dallaire L, Lortie G, Des Rochers M, Clermont R, Vachon C. Parental reaction and adaptability to the prenatal diagnosis of fetal defect or genetic disease leading to pregnancy interruption. PrenatDiagn. 1995; 15(3):249-259.

Gameiro S, Boivin J, Dancet E, de Klerk C, Emery M, Lewis-Jones C, Thorn P, Van den Broeck U, Venetis C, Verhaak CM, Wischmann T, Vermeulen N. Oracción de ESHRE: atención psicosocial rutinaria en infertilidad y reproducción asistida médicamente - una guía para el personal de fertilidad. Hum Reprod. 2015 Nov;

Downloads

Published

2025-07-17

How to Cite

Pérez, S. P., Gutiérrez, A. R., Cameselle-Cortizo, L., Varela, M. O., Rodríguez-Fernández, V., & Cameselle-Teijeiro, J. F. (2025). Rare Diseases: Psychological Aspects Related to Preimplantation Genetic Testing in the Detection of Monogenic Diseases. British Journal of Healthcare and Medical Research, 12(04), 87–94. https://doi.org/10.14738/bjhr.1204.19056